Selma Belfakir

Selma Belfakir


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 May 2024 in TrAC Trends in Analytical Chemistry
Verified
Journal Article
Open access
SBSelma Belfakir
Selma Belfakir
WSWinnie E. Svendsen
Winnie E. Svendsen
Andreas LaustsenAndreas Laustsen
Andreas Laustsen
GRGeorgina Ross
Georgina Ross

31 January 2024 in Scientific Reports
Verified
Journal Article
Open access
PDF file
CKCecilie Knudsen
Cecilie Knudsen
SBSelma Belfakir
Selma Belfakir
PDPelle Degnegaard
Pelle Degnegaard
JJJonas A. Jürgensen
Jonas A. Jürgensen
AHAleksander M. Haack
Aleksander M. Haack
GRGina Ross
Gina Ross
Bothrops and Lachesis are two of Brazil’s medically most relevant snake genera, causing tens of thousands of bites annually. Fortunately, Brazil has good accessibility to high-quality antivenoms at the genus and inter-genus level, enabling the treatment of many of these envenomings. However, the optimal use of these treatments requires that the snake species responsible for the bite is determined. Currently, physicians use a syndromic approach to diagnose snakebite, which can be difficult for medical personnel with limited training in clinical snakebite management. In this work, we have developed a novel monoclonal antibody-based multiplex lateral flow assay for differentiating Bothrops and Lachesis venoms within 15 min. The test can be read by the naked eye or (semi)-quantitatively by a smartphone supported by a 3D-printed attachment for controlling lighting conditions. The LFA can detect Bothrops and Lachesis venoms in spiked plasma and urine matrices at concentrations spanning six orders of magnitude. The LFA has detection limits of 10–50 ng/mL in spiked plasma and urine, and 50–500 ng/mL in spiked sera, for B. atrox and L. muta venoms. This test could potentially support medical personnel in correctly diagnosing snakebite envenomings at the point-of-care in Brazil, which may help improve patient outcomes and save lives.

1 May 2023 in Analytica Chimica Acta
Verified
Journal Article
Open access
CKCecilie Knudsen
Cecilie Knudsen
JJJonas A. Jürgensen
Jonas A. Jürgensen
PKPelle D. Knudsen
Pelle D. Knudsen
IOIrina Oganesyan
Irina Oganesyan
JHJulian A. Harrison
Julian A. Harrison
Andreas LaustsenAndreas Laustsen
Andreas Laustsen
Brazil is home to a multitude of venomous snakes; perhaps the most medically relevant of which belong to the Bothrops genus. Bothrops spp. are responsible for roughly 70% of all snakebites in Brazil, and envenomings caused by their bites can be treated with three types of antivenom: bothropic antivenom, bothro-lachetic antivenom, and bothro-crotalic antivenom. The choice to administer antivenom depends on the severity of the envenoming, while the choice of antivenom depends on availability and on how certain the treating physician is that the patient was bitten by a bothropic snake. The diagnosis of a bothropic envenoming can be made based on expert identification of the dead snake or a photo thereof or based on a syndromic approach wherein the clinician examines the patient for characteristic manifestations of envenoming. This approach can be very effective but requires staff that has been trained in clinical snakebite management, which, unfortunately, far from all relevant staff has. In this article, we describe a prototype of the first lateral flow assay (LFA) capable of detecting venoms from Brazilian Bothrops spp. The monoclonal antibodies for the assay were generated using hybridoma technology and screened in sandwich enzyme-linked immunosorbent assays (ELISAs) to identify Bothrops spp.-specific antibody sandwich pairs. The prototype LFA is able to detect venom from several Bothrops spp. The LFA has a limit of detection (LoD) of 9.5 ng/mL in urine, when read with a commercial reader, and a visual LoD of approximately 25 ng/mL. The work presented here serves as a proof of concept for a genus-specific venom detection kit that could support physicians in diagnosing Bothrops envenomings. Although further optimisation and testing is needed before the LFA can find clinical use, such a device could aid in decentralising antivenoms in the Brazilian Amazon and help ensure optimal snakebite management for even more victims of this highly neglected disease.

11 January 2024 in Toxicon
Verified
Journal Article
Open access
ADAnna Damsbo
Anna Damsbo
CRCharlotte Rimbault
Charlotte Rimbault
NBNick J. Burlet
Nick J. Burlet
AVAnneline Vlamynck
Anneline Vlamynck
IBIda Bisbo
Ida Bisbo
Esperanza Rivera-de-TorreEsperanza Rivera-de-Torre
Esperanza Rivera-de-Torre
Three-finger toxins (3FTxs) have traditionally been obtained via venom fractionation of whole venoms from snakes. This method often yields functional toxins, but it can be difficult to obtain pure isoforms, as it is challenging to separate the many different toxins with similar physicochemical properties that generally exist in many venoms. This issue can be circumvented via the use of recombinant expression. However, achieving the correct disulfide bond formation in recombinant toxins is challenging and requires extensive optimization of expression and purification methods to enhance stability and functionality. In this study, we investigated the expression of α-cobratoxin, a well-characterized 3FTx from the monocled cobra (Naja kaouthia), in three different expression systems, namely Escherichia coli BL21 (DE3) cells with the csCyDisCo plasmid, Escherichia coli SHuffle cells, and Komagataella phaffii (formerly known as Pichia pastoris). While none of the tested systems yielded α-cobratoxin identical to the variant isolated from whole venom, the His6-tagged α-cobratoxin expressed in K. phaffii exhibited a comparable secondary structure according to circular dichroism spectra and similar binding properties to the α7 subunit of the nicotinic acetylcholine receptor. The findings presented here illustrate the advantages and limitations of the different expression systems and can help guide researchers who wish to express 3FTxs.

21 April 2025 in Sensors and Actuators B: Chemical
Verified
Journal Article
Open access
SBSelma Belfakir
Selma Belfakir
EREverardo R. Rodriguez-Rodriguez
Everardo R. Rodriguez-Rodriguez
STSandra W. Thrane
Sandra W. Thrane
ALAnne Ljungars
Anne Ljungars
WSWinnie Svendsen
Winnie Svendsen
GRGeorgina Ross
Georgina Ross

20 April 2026 in RSC Advances
Verified
Journal Article
Open access
PDF file
SBSelma Belfakir
Selma Belfakir
JJJonas A. Jürgensen
Jonas A. Jürgensen
MPMarcus Petersson
Marcus Petersson
MWMax Stæhr Wraae
Max Stæhr Wraae
PMPatrick Munk
Patrick Munk
GRGeorgina Ross
Georgina Ross
A single-domain antibody (VHH)-based sandwich-format lateral flow assay was developed for the detection of cholera toxin from V. cholerae and heat-labile enterotoxin from enterotoxigenic E. coli in human fecal and environmental water samples.